These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 22628226

  • 21. Evaluation of an enzyme immunoassay for the detection of methadone metabolite EDDP [2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine] in urine.
    Wolf CE, Goldstein A, Poklis JL, Poklis A.
    J Clin Lab Anal; 2014 Mar; 28(2):136-40. PubMed ID: 24395735
    [Abstract] [Full Text] [Related]

  • 22. Immunoassay and GC-MS procedures for the analysis of drugs of abuse in meconium.
    ElSohly MA, Stanford DF, Murphy TP, Lester BM, Wright LL, Smeriglio VL, Verter J, Bauer CR, Shankaran S, Bada HS, Walls HC.
    J Anal Toxicol; 1999 Oct; 23(6):436-45. PubMed ID: 10517548
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of the Triage PPY on-site testing device for the detection of dextropropoxyphene in urine.
    Poklis A, Poklis JL, Tarnai LD, Backer RC.
    J Anal Toxicol; 2004 Sep; 28(6):485-8. PubMed ID: 15516300
    [Abstract] [Full Text] [Related]

  • 24. Benzoylecgonine and ecgonine methyl ester concentrations in urine specimens.
    Ramcharitar V, Levine B, Smialek JE.
    J Forensic Sci; 1995 Jan; 40(1):99-101. PubMed ID: 7876811
    [Abstract] [Full Text] [Related]

  • 25. Validity testing of commercial urine cocaine metabolite assays: III. Evaluation of an enzyme-linked immunosorbent assay (ELISA) for detection of cocaine and cocaine metabolite.
    Cone EJ.
    J Forensic Sci; 1989 Jul; 34(4):991-5. PubMed ID: 2760594
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of immunoassay methods for the screening of cocaine metabolites in urine.
    Baugh LD, Allen EE, Liu RH, Langner JG, Fentress JC, Chadha SC, Cook LF, Walia AS.
    J Forensic Sci; 1991 Jan; 36(1):79-85. PubMed ID: 2007883
    [Abstract] [Full Text] [Related]

  • 27. The clinical impact of a false-positive urine cocaine screening result on a patient's pain management.
    Kim JA, Ptolemy AS, Melanson SE, Janfaza DR, Ross EL.
    Pain Med; 2015 Jun; 16(6):1073-6. PubMed ID: 24138673
    [Abstract] [Full Text] [Related]

  • 28. Determination of cocaine and benzoylecgonine by derivatization with iodomethane-D3 or PFPA/HFIP in human blood and urine using GC/MS (EI or PCI mode).
    Aderjan RE, Schmitt G, Wu M, Meyer C.
    J Anal Toxicol; 1993 Jun; 17(1):51-5. PubMed ID: 8429629
    [Abstract] [Full Text] [Related]

  • 29. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs.
    Towt J, Tsai SC, Hernandez MR, Klimov AD, Kravec CV, Rouse SL, Subuhi HS, Twarowska B, Salamone SJ.
    J Anal Toxicol; 1995 Oct; 19(6):504-10. PubMed ID: 8926746
    [Abstract] [Full Text] [Related]

  • 30. Comparative analysis of sweat patches for cocaine (and metabolites) by radioimmunoassay and gas chromatography-positive ion chemical ionization-mass spectrometry.
    Moody DE, Spanbauer AC, Taccogno JL, Smith EK.
    J Anal Toxicol; 2004 Mar; 28(2):86-93. PubMed ID: 15068561
    [Abstract] [Full Text] [Related]

  • 31. Enzyme immunoassay validation for qualitative detection of cocaine in sweat.
    Spiehler V, Fay J, Fogerson R, Schoendorfer D, Niedbala RS.
    Clin Chem; 1996 Jan; 42(1):34-8. PubMed ID: 8565229
    [Abstract] [Full Text] [Related]

  • 32. Does Lidocaine Cause False Positive Results on Cocaine Urine Drug Screen?
    Kim E, Murray BP, Salehi M, Moran TP, Carpenter JE, Koch DD, Ritchie JC, Schindler JM, Morgan BW.
    J Med Toxicol; 2019 Oct; 15(4):255-261. PubMed ID: 31264143
    [Abstract] [Full Text] [Related]

  • 33. Validity testing of the TDx Cocaine Metabolite Assay with human specimens obtained after intravenous cocaine administration.
    Cone EJ, Menchen SL, Mitchell J.
    Forensic Sci Int; 1988 Jun; 37(4):265-75. PubMed ID: 3410396
    [Abstract] [Full Text] [Related]

  • 34. Simultaneous GC-MS analysis of meta- and para-hydroxybenzoylecgonine and norbenzoylecgonine: a secondary method to corroborate cocaine ingestion using nonhydrolytic metabolites.
    Klette KL, Poch GK, Czarny R, Lau CO.
    J Anal Toxicol; 2000 Oct; 24(7):482-8. PubMed ID: 11043650
    [Abstract] [Full Text] [Related]

  • 35. Immunoassay for detection of cocaine/metabolites in oral fluids.
    Niedbala RS, Kardos K, Fries T, Cannon A, Davis A.
    J Anal Toxicol; 2001 Oct; 25(1):62-8. PubMed ID: 11216002
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Roche DAT immunoassay: sensitivity and specificity testing for amphetamines, cocaine, and opiates in oral fluid.
    Crooks CR, Brown S.
    J Anal Toxicol; 2010 Mar; 34(2):103-9. PubMed ID: 20223103
    [Abstract] [Full Text] [Related]

  • 39. Reliability of the cloned-enzyme donor immunoassay (CEDIA) for cocaine in human serum in the range between the detection limit and the cut-off.
    Schütz H, Auch J, Erdmann F, Weiler G, Verhoff MA.
    Arzneimittelforschung; 2006 Mar; 56(6):414-20. PubMed ID: 16889124
    [Abstract] [Full Text] [Related]

  • 40. Meconium analysis for cocaine: a validation study and comparison with paired urine analysis.
    Lewis DE, Moore CM, Leikin JB, Koller A.
    J Anal Toxicol; 1995 Mar; 19(3):148-50. PubMed ID: 7564291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.